Investors Should Watch: Discovery Communications, Inc. (NASDAQ:DISCA), Novavax, Inc. (NASDAQ:NVAX), Alibaba Group Holding Ltd (NYSE:BABA), Celgene Corporation (NASDAQ:CELG), GigaMedia Ltd. (NASDAQ:GIGM)

Topeka Capital Markets restated their buy rating on shares of Discovery Communications (NASDAQ:DISCA) in a research note issued to investors on Monday. Discovery Communications, Inc. (NASDAQ:DISCA) belongs to Services sector. Its net profit margin is 23.00% and weekly performance is -2.66%. On last trading day company shares ended up $33.97. Discovery Communications, Inc. (NASDAQ:DISCA) distance…

Read More

Morning Alert: Tekmira Pharmaceuticals (NASDAQ:TKMR), Novavax (NASDAQ:NVAX), Relypsa (NASDAQ:RLYP), VMware, Inc. (NYSE:VMW), Cameron International (NYSE:CAM)

Equities researchers at Leerink Swann began coverage on shares of Tekmira Pharmaceuticals (NASDAQ:TKMR) in a research report issued on Monday. Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR) belongs to Healthcare sector. Its weekly performance is -18.28%. On last trading day company shares ended up $19.45. Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR) distance from 50-day simple moving average (SMA50) is 48.15%. Stock analysts…

Read More

Investors Alert – Google (NASDAQ:GOOG) , International Business Machines (NYSE:IBM) , Lands’ End, Novavax (NASDAQ:NVAX) , WOLVERINE BANCORP, INC. (NASDAQ:WBKC)

A federal judge in New York authorized a warrant requiring Google Inc. (NASDAQ:GOOGL) to give prosecutors access to a user’s inbox. U.S. Magistrate Gabriel Gorenstein permitted investigators to request the total contents of a Gmail account. Google Inc (NASDAQ:GOOG) stock performance was -0.94% in last session and finished the day at $589.47. Traded volume was…

Read More

Healthcare ACtive Runners: Teva Pharmaceutical Industries (NYSE:TEVA), Exelixis (NASDAQ:EXEL), Novavax (NASDAQ:NVAX), Abbott Laboratories (NYSE:ABT), Celgene (NASDAQ:CELG)

Just a month ago, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) snapped up portfolio company, San Mateo, CA-based Labrys Biologics, for $200 million up front and another $625 million in milestones. That deal came less than two years after Labrys was formed, and venBio partner and co-founder Corey Goodman told Xconomy at the time that venBio had contributed $8.5…

Read More

Biotech Insider Buying: OvaScience Inc (NASDAQ:OVAS), BioTime (NYSEMKT:BTX), Insys Therapeutics (NASDAQ:INSY), Novavax (NASDAQ:NVAX), ImmuCell Corporation (NASDAQ:ICCC)

Ovascience Inc (NASDAQ:OVAS) major shareholder Fund L.P. Longwood bought 100,000 shares of the company’s stock on the open market in a transaction dated Friday, March 7th. The stock was purchased at an average cost of $10.00 per share, for a total transaction of $1,000,000.00. OvaScience Inc (NASDAQ:OVAS) stock performance was -2.98% in last session and…

Read More

Healthcare most active stocks: Orexigen Therapeutics (NASDAQ:OREX), Express Scripts Holding (NASDAQ:ESRX), Karyopharm Therapeutics Inc (NASDAQ:KPTI), Novavax (NASDAQ:NVAX), Bristol-Myers Squibb (NYSE:BMY)

According to a statement of Orexigen Therapeutics, Inc. (NASDAQ:OREX), the U.S Food and Drug Administration hasn’t given a green signal to its new drug which helps people in fighting from obesity. One of the spokespersons of the company said,” FDA has delayed its decision on our drug for as much as 3 months. So we…

Read More